Gregory Gressel, MD
Enriched profileClinical Associate Professor · Michigan State University College of Human Medicine
Gregory Gressel is Clinical Associate Professor at Michigan State University College of Human Medicine. OpenAlex indexes 88 publications with 677 citations (h-index 14).
Data verified 5 Nov 2026
Overview
Updated 7 Nov 2026
Gregory Gressel, MD, is Clinical Associate Professor at Michigan State University College of Human Medicine. The public record shows 88 publications with 677 citations (h-index 14), centered on Endometrial and Cervical Cancer Treatments, Ovarian cancer diagnosis and treatment, Venous Thromboembolism Diagnosis and Management. It also documents industry payments reported by 11 companies.
- Most recent indexed publication: 2025 · Journal of clinical oncology
- Top research focus: Endometrial and Cervical Cancer Treatments
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 7 Nov 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex, matched via ORCID. 4 in PubMed. Counts exclude supporting files.
Citations across these publications.
H-index from these publications. i10-index 18.
Clinical & industry
trials, payments and federal fundingFederally funded research awards.
Public positions
sourced statements on record- Principal investigator
MSU and Corewell Health 1M research project on the HTR3A serotonin receptor in high-grade endometrial cancer
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →innovationcenter.msu.edu ↗
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Clinical trials
We didn't find any investigator roles for this person on ClinicalTrials.gov. Why? →
Industry payments
Updated 6 Nov 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Eisai Inc.Program year20255 payments
- ABBVIE INC.Program year20256 payments
- PFIZER INC.Program year20251 payment
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Congress activity
Updated 6 Nov 2026
8 congress contributions (2016–2024) across AACR, ASCO per OpenAlex. The most recent:
- Phase II/III study of paclitaxel/carboplatin alone or combined with either trastuzumab and hyaluronidase-oysk or pertuzumab, trastuzumab, and hyaluronidase-zzxf in HER2 positive, stage I-IV endometrial serous carcinoma or carcinosarcoma (NRG-GY026).
ASCO Annual Meeting
ASCO2024Co-authorPosterTrials in progress - Association of the Khorana Score with development of venous thromboembolism in ovarian cancer.
ASCO Annual Meeting
ASCO2021Co-author - Race-related disparities in patterns of uterine cancer recurrence.
ASCO Annual Meeting
ASCO2021Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 6 Nov 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update.
Journal of clinical oncology
Guideline2025 - Low molecular weight serum cell-free DNA concentration is associated with clinicopathologic indices of poor prognosis in women with uterine cancer.
Journal of translational medicine
Article2020 - Endometrial Carcinoma in a 26-Year-Old Patient with Bardet-Biedl Syndrome.
Case reports in obstetrics and gynecology
Case Report2018
Most-cited works
by citation count (OpenAlex)Network
Updated 6 Nov 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 6 Nov 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/gregory-gressel-md
verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by others
where others cite or feature them- Other
humanmedicine.msu.edu/news/2024-msu-corewell-mark-17-year-partnership.html
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →humanmedicine.msu.edu ↗ - Other
applykite.com/professors/gregory-gressel-536a77a4-60e9-4300-92fe-612d1154c1fa
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →applykite.com ↗ - Other
sgo.org/news/germline-and-somatic-testing-for-ovarian-cancer-an-sgo-clinical-practice-statement
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sgo.org ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 6 Nov 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →providers.corewellhealth.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →convenehealthcare.com ↗
Editorial & leadership roles
journal and society appointments- Member
Uterine Corpus Cancer Subcommittee, NRG Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nrgoncology.org ↗
Awards & honors
honors on the public record- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →sgo.org ↗
Secondary affiliations
appointments beyond the home institution- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- verifiedCorroborated by FindMyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →orcid.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →innovationcenter.msu.edu ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Baha Sibai, MD
McGovern Medical School at UTHealth Houston
Robert Coleman, MD
Vaniam Group
Bradley Monk, MD
Florida Cancer Specialists & Research Institute
Angeles Secord, MD
Duke University School of Medicine